Clinical Cases Podcast Series-FREE NO CME-Nonopioid Pharmacologic Treatments

Nonopioid Pharmacologic Treatments

Pdf Summary

This toolkit section outlines evidence-based nonopioid pharmacologic options for multimodal pain management, emphasizing opioid-sparing strategies and condition-specific choices. It summarizes major medication classes: nonopioid analgesics (acetaminophen/APAP, NSAIDs), antidepressants (SNRIs/TCAs), antipsychotics (haloperidol, olanzapine), gabapentinoids/antiepileptics, glucocorticoids (dexamethasone), local anesthetics (lidocaine/bupivacaine), muscle relaxants/antispasmodics, and topical agents (capsaicin, diclofenac, lidocaine, menthol).<br /><br />APAP is described as effective for mild–moderate pain (NNT ~4.1) and, combined with ibuprofen (APAP 1000 mg + ibuprofen 400 mg), can be as effective as common opioid/APAP combinations for acute extremity pain. Dosing is typically 400–1000 mg every 4–8 hours with attention to hepatotoxicity risk; recommended max is often ≤3 g/day for extended use, and ≤2 g/day in cirrhosis. Liver function monitoring and avoiding duplicate APAP products are stressed.<br /><br />For chronic/neuropathic pain, SNRIs (duloxetine, venlafaxine) and TCAs (amitriptyline, nortriptyline) are highlighted as first-line options, with low-dose TCAs showing strong efficacy (average NNT 2.6). Guidance includes titration schedules, delayed onset, avoidance of abrupt discontinuation, and safety monitoring (serotonin syndrome for SNRIs; QT monitoring and anticholinergic cautions for TCAs, especially in older adults).<br /><br />Haloperidol and olanzapine are presented as analgesic/antiemetic options for difficult abdominal pain syndromes such as cyclic vomiting and cannabis hyperemesis, with QT and sedation/orthostasis precautions.<br /><br />Other adjuncts include topical capsaicin (including for cannabis hyperemesis), single-dose dexamethasone for migraines/dental pain/sore throat, dicyclomine for cramping/IBS pain, gabapentinoids for neuropathy (renal dosing and misuse/respiratory depression cautions), and local/topical lidocaine for procedures and neuropathic or musculoskeletal pain.<br /><br />NSAIDs are effective, especially with APAP, but require careful GI/cardiac/renal risk assessment, shortest-duration use, and monitoring; topical diclofenac is recommended when systemic risk is high.

Keywords

nonopioid analgesics

multimodal pain management

acetaminophen

NSAIDs

neuropathic pain

duloxetine

amitriptyline

gabapentinoids

topical lidocaine

opioid-sparing strategies